This workshop will focus on Parallel Trade and potential impact of Brexit.
We will briefly go over the background on Parallel Trade, products of interest and explore trade across boarders (both ways).
Stock shortages & FMD were the challenges faced during 2019. We will review the status for 2020.
Expectations from Brexit for pharma industry and regulatory bodies. Has the industry simply now planned for all eventualities given we have had many false starts for Brexit and deadlines?
How parallel trade has evolved in the UK and rest of EU. Discuss various business models adopted by industry. What does the future hold for Parallel Trade?